As such, the residual SYNTAX score (RSS) (6, 7) was recently developed to quantitatively assess the degree and complexity of residual stenoses by recalculating the SYNTAX score (SS) after PCI (8, 9) . Similarly, the SYNTAX revascularization index (SRI) was introduced as another quantification tool to assess the proportion of CAD that has been treated by PCI (10, 11) .
Recent studies have found that functional significance of a lesion on the basis of fractional flow reserve (FFR) is a more important determinant of future adverse cardiac events than the angiographic appearance of the lesions (12, 13) . PCI on angiographically significant lesions that are not functionally significant on the basis of FFR can be deferred safely with good longterm outcomes (14) . Therefore, we hypothesized that after "functionally" complete revascularization with FFR guidance in patients with multivessel CAD (15) , the residual angiographic disease, which is not functionally significant, would not be predictive of outcomes, as assessed by the RSS or SRI. Accordingly, the primary goal of the present study is to investigate the prognostic value of these 2 quantification systems in patients enrolled in the FFR-guided PCI cohort of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) trial (16) (17) (18) , who underwent functionally complete revascularization with FFR guidance.
METHODS STUDY DESIGN AND PATIENT POPULATION.
The detailed study protocol has been published previously (16, 18, 19) . In brief, the FAME trial is a prospective, randomized, controlled, multicenter trial investigating the superiority of FFR-guided PCI over angiography-guided PCI in patients with multivessel CAD (NCT00267774). In patients with multivessel CAD amenable to PCI, the investigators indicated which lesions had at least 50% diameter stenosis and were thought to require PCI. Thereafter, patients were randomly assigned to either FFR-guided or angiography-guided PCI. In patients assigned to FFR-guided PCI, only functionally significant lesions with FFR #0.80 were treated with PCI, and functionally insignificant lesions with FFR >0.80
were intentionally left untreated; whereas in patients assigned to angiography-guided PCI, all indicated lesions were treated without measurement of FFR.
Because patients assigned to angiography-guided PCI (8, 9, 20) . In brief, the SS was calculated from the pre-procedural angiogram, in which each coronary lesion producing $50% diameter stenosis in vessels $1.5 mm by visual estimation was scored separately using the SS algorithm from the SYNTAX Score website and added to obtain the Post-procedural angiograms from 50 patients were randomly selected and reanalyzed by the same interventional cardiologist and a second independent interventional cardiologist to assess intraobserver and interobserver variability of the RSS.
ENDPOINTS. An independent clinical events committee whose members were blinded to treatment strategy adjudicated all events. The primary endpoint of this reanalysis was the same as that of the original FAME trial: major adverse cardiac events (MACE) (defined as a composite of all-cause death, myocardial infarction, or any repeat revascularization) and its components (all-cause death, myocardial infarction, repeat revascularization, and death or myocardial infarction) at 1 year after the index procedure among the RSS and SRI subgroups. The previously The FSS and RSS were significantly correlated with the SS, whereas the RSS was not correlated with the FSS. The SRI was not correlated with the SS. On the other hand, the SRI was positively correlated with the FSS and negatively correlated with the RSS. One patient had a higher RSS value than an original SS value due to a complication during PCI, resulting in a negative SRI value. Each point may represent >1 patient. Abbreviations as in Figure 1 .
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A Comparisons of outcomes at 1 year among RSS and SRI subgroups are summarized in Table 2 . and SRI, showed no significant separation (Online Tables 1 and 2 ). Comparisons of outcomes at 2 years among RSS and SRI subgroups are summarized in Online Table 3 .
MACE and each component of MACE were not different among the RSS and SRI subgroups at 2 years. KaplanMeier curves at 2 years, stratified by RSS and SRI, showed no significant separation (log-rank p ¼ 0.87 for the RSS subgroups and log-rank p ¼ 0.93 for the SRI subgroups) (Online Figure 2) . Similarly, when stable and unstable patients were analyzed separately or when patients with SS 0 to 22 and with SS >23 were analyzed separately, Kaplan-Meier curves at 2 years, stratified by RSS and SRI, showed no significant separation (Online Tables 1 and 2 ).
DISCUSSION
The principal finding of the present study is that the RSS and the SRI do not predict MACE at 1-and 2-year follow-up in patients with multivessel CAD after Repeat revascularization 25 (5.9) 4 (6.5) 4 (3.1) 8 (7.9) 9 (6.6) 0.45
Death or myocardial infarction 31 (7.3) 6 (9.7) 9 (7.1) 5 (5.0) 11 (8.0) 0.69 Values are n (%).
MACE ¼ major adverse cardiac events (defined as a composite of all-cause death, myocardial infarction, or any repeat revascularization); MI ¼ myocardial infarction; other abbreviations as in Table 1 . Similarly, the finding that the SRI was positively correlated with the FSS explains that the SRI had no prognostic value because the SRI should be negatively correlated with the FSS to be prognostic. With each decrement of the SRI, the number of lesions indicated tended to increase; however, the actual number/ length of stents implanted decreased, and the longterm outcome was similar. These findings suggest that a scoring system with a purely anatomic approach may be insufficient, not only for the pre-procedural assessment, but also for the post-procedural assessment for predicting outcome after PCI.
The RSS and SRI have been shown to be associated with worse long-term outcomes after angiographyguided PCI, suggesting the importance of angiographically complete revascularization in managing patients with stable angina and multivessel CAD (6, 7, 11, (22) (23) (24) (25) (26) . Given that functionally insignificant lesions do not tend to contribute to outcome when left untreated, the integration of functional information into the RSS and SRI should improve the prognostic value, just as was seen with the relationship between the SS and FSS (20) , and as we document in this report. Although angiographically complete revascularization may be better than angiographically incomplete revascularization, our study supports the concept that functionally complete revascularization is as good as angiographically complete revascularization, if not better. "Angiographically" complete revascularization results in PCI of all angiographically significant lesions, which include both functionally significant and insignificant lesions. "Functionally" complete revascularization focuses on PCI of only functionally significant lesions, leaving functionally insignificant CAD for medical treatment, and in this manner, optimizing the benefit of PCI while minimizing its risk. Studies have shown that functionally significant lesions result in increased cardiac events without PCI, whereas functionally insignificant disease is treated more effectively with medical therapy. In this study, we found that functionally insignificant lesions have no prognostic value, irrespective of the untreated CAD assessed by the RSS or the extent of revascularization assessed by the SRI. 
